Sequenom, Inc. (SQNM) Stock Ratings

View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:


100% of 1 ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks

Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
MikeAlbert MikeAlbert 11/17/2015 3 months $1.67 $1.78 +6.59% 6 Active
Comments: company has solid patent base
Netteligent Netteligent 10/02/2015 1 month $2.41 $1.75 -27.39% 27 Ended
Bandolero Bandolero 12/05/2014 3 months $3.77 $3.65 -3.18% 3 Ended
Comments: Target Price 2.00
winxart winxart 01/15/2014 1 Year $2.58 $3.68 +42.64% 42 Ended
Comments: 80%year revenue growth,could achieve break-even and +cash flow on Q4,EUROPE famous potential
VictoriaMillerP VictoriaMillerP 01/09/2014 3 months $2.46 $2.49 +1.22% 1 Ended
Comments: Just received a European patent
JOKER66 JOKER66 05/10/2013 1 day $3.57 $4.27 +19.61% 19 Ended
inBestment inBestment 11/22/2012 1 month $4.25 $4.00 -5.88% -5 Ended
TR_S TR_S 06/01/2012 3 months $3.88 $3.78 -2.58% -2 Ended
Comments: This stock is undervalued
voodoo_2 voodoo_2 08/18/2010 3 months N/A Ended
fait fait 01/29/2010 3 months N/A Ended
redsocks redsocks 01/01/2010 3 months N/A Ended
romsel romsel 12/15/2009 3 months N/A Ended
Comments: very speculative play with huge upside potenial ($ 100+) if DS Test works
Scott  Cline Scott Cline 12/07/2009 3 months N/A Ended
Comments: A strong stock, gets knocked down, but recovers again within months. great 1/2 price stock

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.